Nvidia-backed AI drug developer Iambic is raising $150 million in U.S. IPO Oct 15, 2026 · Cris Tolomia The San Diego company's stock is expected to begin trading on Nasdaq Thursday under the ticker IAM, with the offering expected to close Friday Read more »
.jpg?branch=production)
